PTC Therapeutics | PTCT - 負債





負債 変化する 日付
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 57.32B 2.72B 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
Daiichi Sankyo JPY 300.48B 99.34B 2026-03
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Gilead Sciences USD 22.17B 2.76B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
TG Therapeutics USD 754.44M 884K 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Xencor USD 175.16M 12.58M 2026-03